264 related articles for article (PubMed ID: 19620237)
21. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
Smith TH; Sim-Selley LJ; Selley DE
Br J Pharmacol; 2010 Jun; 160(3):454-66. PubMed ID: 20590557
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch.
Kleyer J; Nicolussi S; Taylor P; Simonelli D; Furger E; Anderle P; Gertsch J
Biochem Pharmacol; 2012 May; 83(10):1393-412. PubMed ID: 22387618
[TBL] [Abstract][Full Text] [Related]
23. Signal transduction via cannabinoid receptors.
Dalton GD; Bass CE; Van Horn CG; Howlett AC
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):422-31. PubMed ID: 19839935
[TBL] [Abstract][Full Text] [Related]
24. Signal transduction activated by cannabinoid receptors.
Díaz-Laviada I; Ruiz-Llorente L
Mini Rev Med Chem; 2005 Jul; 5(7):619-30. PubMed ID: 16026308
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.
Maccarrone M; Bernardi G; Agrò AF; Centonze D
Br J Pharmacol; 2011 Aug; 163(7):1379-90. PubMed ID: 21323908
[TBL] [Abstract][Full Text] [Related]
26. Efficacy in CB1 receptor-mediated signal transduction.
Howlett AC
Br J Pharmacol; 2004 Aug; 142(8):1209-18. PubMed ID: 15308578
[TBL] [Abstract][Full Text] [Related]
27. Design and development of stapled transmembrane peptides that disrupt the activity of G-protein-coupled receptor oligomers.
Botta J; Bibic L; Killoran P; McCormick PJ; Howell LA
J Biol Chem; 2019 Nov; 294(45):16587-16603. PubMed ID: 31467080
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.
Stadel R; Ahn KH; Kendall DA
J Neurochem; 2011 Apr; 117(1):1-18. PubMed ID: 21244428
[TBL] [Abstract][Full Text] [Related]
29. Gene ancestry of the cannabinoid receptor family.
Anday JK; Mercier RW
Pharmacol Res; 2005 Dec; 52(6):463-6. PubMed ID: 16118055
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders.
Vinod KY; Hungund BL
Expert Opin Ther Targets; 2006 Apr; 10(2):203-10. PubMed ID: 16548770
[TBL] [Abstract][Full Text] [Related]
31. Functional selectivity in cannabinoid signaling.
Varga EV; Georgieva T; Tumati S; Alves I; Salamon Z; Tollin G; Yamamura HI; Roeske WR
Curr Mol Pharmacol; 2008 Nov; 1(3):273-84. PubMed ID: 20021440
[TBL] [Abstract][Full Text] [Related]
32. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.
Rozenfeld R; Devi LA
FASEB J; 2008 Jul; 22(7):2311-22. PubMed ID: 18267983
[TBL] [Abstract][Full Text] [Related]
33. Distinct second extracellular loop structures of the brain cannabinoid CB(1) receptor: implication in ligand binding and receptor function.
Shim JY; Rudd J; Ding TT
Proteins; 2011 Feb; 79(2):581-97. PubMed ID: 21120862
[TBL] [Abstract][Full Text] [Related]
34. The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.
Wilkerson JL; Milligan ED
ISRN Anesthesiol; 2011; 2011(2011):. PubMed ID: 22442754
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid Receptor Signaling is Dependent on Sub-Cellular Location.
Thomas A; Lobingier BT; Schultz C; Laguerre A
bioRxiv; 2024 Mar; ():. PubMed ID: 38562854
[TBL] [Abstract][Full Text] [Related]
36. "De-liver-ance" from CB(1): a way to counteract insulin resistance?
Di Marzo V
Gastroenterology; 2012 May; 142(5):1063-6. PubMed ID: 22465721
[No Abstract] [Full Text] [Related]
37. GPCR Signaling From Intracellular Membranes - A Novel Concept.
Stäubert C; Schöneberg T
Bioessays; 2017 Dec; 39(12):. PubMed ID: 29136291
[No Abstract] [Full Text] [Related]
38. Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane.
Ghovanloo MR; Arnold JC; Ruben PC
Front Physiol; 2023; 14():1211230. PubMed ID: 37228821
[No Abstract] [Full Text] [Related]
39. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
Pertwee RG; Howlett AC; Abood ME; Alexander SP; Di Marzo V; Elphick MR; Greasley PJ; Hansen HS; Kunos G; Mackie K; Mechoulam R; Ross RA
Pharmacol Rev; 2010 Dec; 62(4):588-631. PubMed ID: 21079038
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
